1. Introduction {#s0005}
===============

Since the discovery of expression of the Trpc2 cation channel in rat vomeronasal organ (VNO) ([@bb0075]), Trpc2 expression was thought to be restricted to VSNs in mouse. We recently challenged this belief by immunohistochemistry (IHC) with the Trpc2 antibody that was used in rat ([@bb0075]) and by in situ hybridization (ISH) ([@bb0110]). We also generated a Trpc2-IRES-taulacZ knockin mouse strain ([@bb0110]). We found that the mouse MOE actually abounds with Trpc2 + cells, from early stages in development throughout adulthood. We identified two types of Trpc2 + MOE cells, which we refer to as type A and type B cells. These cell types can be distinguished at the single-cell level by *Adcy3* expression: type A cells express *Adcy3*, and type B cells do not express *Adcy3*. The cell bodies of type A cells form a semicontinuous layer throughout the MOE just below the sustentacular cell layer. The cell bodies of type B cells reside within the lateral region of the MOE and are located at all positions along the basal-to-apical dimension of the MOE. One third of MOE cells labeled with *Olfr68*/*69* riboprobes are type A cells. We were unable to find ISH evidence of expression of the known chemosensory G-protein coupled receptor genes or signaling components in type B cells. Type A and type B cells appear to share only *Trpc2* expression with VSNs, and are thus not VSNs that are misplaced in the MOE.

Here, we describe a novel gene-targeted knockin mutation in the *Trpc2* locus, designed to coexpress Trpc2 with the red-fluorescent axonal marker taumCherry. We picked single taumCherry + MOE cells from the lateral region of the MOE (type B cells) and carried out RT-PCR analyses. We confirm and extend our ISH observations that type B cells do not express OR or VR genes. Next we applied LongSAGE to single taumCherry + cells, and came across the soluble guanylate cyclase *Gucy1b2*. We show by ISH and by IHC with a custom Gucy1b2 antibody that Gucy1b2 expression is specific to type B cells in the MOE. We counted \~ 16,000 *Gucy1b2*+ cells in the MOE of C57BL/6 mice at three weeks, and found that 97% of these cells are *Trpc2*+. In mice of a novel gene-targeted Gucy1b2-IRES-tauGFP knockin strain, GFP + axons coalesce into a few glomeruli ventrally and posteriorly in the main olfactory bulb. Our results thus define Gucy1b2 as a marker for type B cells in the MOE. The Gucy1b2-IRES-tauGFP strain will enable physiological experiments in type B cells to determine in which regard these cells differ functionally from type A cells, canonical OSNs, and VSNs.

2. Results {#s0010}
==========

2.1. The Trpc2-IRES-taumCherry knockin mouse strain {#s0025}
---------------------------------------------------

We have previously described a Trpc2-IRES-taulacZ knockin strain, in which Trpc2 + cells coexpress the axonal marker tauβgalactosidase ([@bb0110]). This mouse strain lends itself well to X-gal histochemistry and IHC with βgalactosidase antibodies, but is less suited to study live, unfixed Trpc2 + cells. We therefore generated another mouse strain by gene targeting using the red fluorescent protein mCherry ([@bb0135]). The genetic design of the Trpc2-IRES-taumCherry targeted mutation ([Fig. 1](#f0005){ref-type="fig"}A) mirrors that of Trpc2-IRES-taulacZ. The *IRES* sequence allows for cotranslation of intact Trpc2 polypeptide with the axonal marker taumCherry, and the endogenous 3′ untranslated sequence of *Trpc2* is retained within the transcripts generated from the mutant allele. This mouse strain is publicly available from The Jackson Laboratory.

In a coronal section of the VNO of a homozygous Trpc2-IRES-taumCherry mouse, the intense red fluorescence reflects the broad and high expression of Trpc2 across VSNs ([Fig. 1](#f0005){ref-type="fig"}B). A coronal section of the MOE reveals scattered red-fluorescent cells that are also Trpc2 + by IHC ([Fig. 1](#f0005){ref-type="fig"}B). There is thus concordance at the cellular level between the intrinsic red fluorescence and the Trpc2 immunoreactive signal, as can be expected from the *IRES* design. In whole mounts, red-fluorescent cells in the VNO project their axons to the accessory olfactory bulb (AOB) and coalesce into a few glomeruli on the ventral aspect of the main olfactory bulb ([Fig. 1](#f0005){ref-type="fig"}C). The Trpc2-IRES-taumCherry strain mimics the expression pattern seen in the Trpc2-IRES-taulacZ strain.

2.2. Single-cell RT-PCR {#s0030}
-----------------------

We dissected whole olfactory mucosa (WOM) ([@bb0045]) from the lateral region of the MOE of homozygous Trpc2-IRES-taumCherry mice at 8 weeks, and dissociated the tissue samples into single cells. The lateral region of the MOE is enriched in type B cells ([@bb0110]), but contains also type A cells, which are present throughout the MOE. The expression level of Trpc2 in adult mice is higher in type B cells than in type A cells. We thus picked the brightest mCherry + cells using micromanipulators under a fluorescence microscope. We carried out RT-PCR with *mCherry* and *Omp* primers on 59 WOM-derived cells (m-cells), as well as on 31 VNO-derived cells (v-cells). We identified 24 and 18 cells, respectively, from which both transcripts could be amplified; we call these 42 cells the validated cells. An example of the results from a validated WOM cell (m37) is given in [Fig. 2](#f0010){ref-type="fig"}A. Cell m37 is positive for *mCherry*, *Omp*, *Cnga2*, and *Gnao1*, very weakly positive for *Gnal*, and negative for *Adcy3* and *Gnai2*; this gene expression profile is characteristic of type B cells. Next we subjected validated m-cells to degenerate RT-PCR for OR genes: we could not obtain a distinct RT-PCR product from 0/12 validated m-cells ([Fig. 2](#f0010){ref-type="fig"}B). However a strong RT-PCR product was obtained from o1 and o2, two randomly picked single cells from WOM of a heterozygous OMP-YFP gene-targeted mouse; these cells are most likely canonical, OR-expressing OSNs. Indeed, sequencing the PCR products revealed that o1 expressed *Olfr1183*, and o2 expressed *Olfr1607*. We did not obtain a band with degenerate primers for *Taar* genes ([@bb0065]) from 8 validated m-cells (data not shown). Next we applied 11 subfamily-specific degenerate primer sets for *V1ra* to *V1rk* subfamilies covering all *Vmn1r* members ([@bb0115]). Strong PCR products were obtained from 5/6 validated v-cells, but not from 9 validated m-cells with any of these 11 primer sets. Sequencing the PCR products revealed expression of *Vmnr68* in v1 and v5, *V1re13*/*Vmn1r71* in v2, *V1rf4*/*Vmn1r236* in v3, and *V1rg3*/*Vmn1r80* in v10; an example is given for the *V1rg* primer set in [Fig. 2](#f0010){ref-type="fig"}C. It is well established that in basal VSNs, one or more genes of the seven-gene family-C *Vmn2r* are coexpressed with one family-ABD *Vmn2r* gene ([@bb0030; @bb0035; @bb0140]). Using two sets of degenerate RT-PCR primers for family-C *Vmn2r* genes, we could amplify a band from 1/2 validated v-cells (v28) with primer set A and 2/2 validated v-cells with primer set B (v28 and v32), but not from 9 validated m-cells ([Fig. 2](#f0010){ref-type="fig"}D). We performed RT-PCR with degenerate primers for *Fpr* genes, the third class of chemosensory G-protein coupled receptor genes expressed in the VNO ([@bb9100; @bb0070]). We obtained strong PCR products from v6 and v36, and identified by sequencing expression of *Fpr-rs4* expression from v6 and *Fpr-rs6* in v36; no PCR products were obtained from 6 validated m-cells (data not shown).

Thus, our single-cell RT-PCR analyses on 24 type B cells provide another line of negative evidence that these cells do not express known chemosensory G-protein coupled receptor genes. However some of these genes may not be detectable by the degenerate RT-PCR primers.

2.3. Long Serial Analysis of Gene Expression {#s0035}
--------------------------------------------

The targeted search for expression of known chemosensory G-protein coupled receptor genes and components of signaling pathways by ISH ([@bb0110]) and here by single-cell RT-PCR has not unveiled any evidence for such expression. In an alternative strategy, we took a non-targeted, discovery-oriented approach by applying a variant of SAGE called LongSAGE ([@bb0150; @bb0125; @bb0120; @bb0020]) on three red-fluorescent cells from Trpc2-IRES-taumCherry mice: two type B cells and on one VNO cell. The type B cells were validated by RT-PCR for expression of *Gapdh*, *Omp*, *mCherry*, *Cnga2*, and *Gnao* and no expression of *Adcy3*, and the VNO cell was validated for expression of *Gapdh*, *Omp*, *mCherry*, *Gnao*, and *family-C Vmn2r*. In LongSAGE, "long" tags representing 17 bp cDNA segments are concatenated, and the concatemers cloned and sequenced. Examples of nucleotide sequences are shown in [Fig. 3](#f0015){ref-type="fig"}A, B. From VNO-derived cell v28, we obtained tags for *Vmn2r37* or *Vm2nr42* (family-ABD genes) and *Vmn2r7* (family-C gene); the *Omp* gene was also represented in the collection of 5998 tags ([Fig. 3](#f0015){ref-type="fig"}C). By contrast, in type B cells m85 and m93, there were no tags for OR or VR genes among the 5195 and 5653 tags, respectively; the *Omp* gene was well represented in both cells ([Fig. 3](#f0015){ref-type="fig"}C). We were intrigued by the presence of tags for *Gucy1b2* in both m85 and m93. This soluble guanylate cyclase has been poorly studied, and has not been characterized in vertebrate olfactory systems. We decided to evaluate this gene as a marker for type B cells in the MOE.

2.4. Gucy1b2 RNA and Gucy1b2 protein expression in the MOE {#s0040}
----------------------------------------------------------

We performed three-color ISH in the MOE of wild-type C57BL/6 mice with riboprobes for *Trpc2*, *Gucy1b2*, and *Adcy3* ([Fig. 4](#f0020){ref-type="fig"}A). Type A cells are *Gucy1b2*−, and most type B cells are *Gucy1b2*+, thus providing the first marker that can distinguish type B cells positively from type A cells at the single-cell level. An occasional *Trpc2*+ cell in the lateral region of the MOE, where type B cells are enriched, appears to be *Gucy1b2*−. These occasional cells could be type A cells (because this cell type is present throughout the MOE), immature type B cells, or represent another, unrecognized but minor Trpc2 + cell type in the MOE. By two-color ISH in three C57BL/6 mice at three weeks, we counted 16,115 ± 929 (SE) *Gucy1b2*+ cells in the MOE, of which 15,630 ± 1023 (97.0 ± 1.2%) are *Trpc2*+.

Encouraged by the promise of *Gucy1b2* as a type B cell marker, we generated a rabbit antiserum against a 22 amino acid sequence near the C-terminus of the Gucy1b2 protein. We performed IHC on coronal sections of the MOE of homozygous Trpc2-IRES-taumCherry mice ([Fig. 4](#f0020){ref-type="fig"}B). Consistent with the ISH data, Type A cells are Gucy1b2 −, and most type B cells are Gucy1b2 +.

Thus, our ISH and IHC studies validate *Gucy1b2* as a marker for type B cells within the MOE.

2.5. Expression of other signaling molecules {#s0045}
--------------------------------------------

Type B cells do not express *Adcy3* but express the cyclic nucleotide-gated channel subunit *Cnga2* ([Fig. 5](#f0025){ref-type="fig"}A). There must thus be a source of cAMP or cGMP, and Gucy1b2 is an enzyme that catalyzes the production of cGMP. We carried out further ISH analyses for other signaling molecules. *Cnga4*, another cyclic nucleotide-gated channel subunit ([@bb0040]), is not expressed in type B cells but is expressed widely across canonical OSNs ([Fig. 5](#f0025){ref-type="fig"}B). Among the phosphodiesterases, enzymes that catalyze the degradation of cAMP and/or cGMP, we identify expression of *Pde1c*, *Pde4a*, and *Pde6d* in type B cells ([Fig. 5](#f0025){ref-type="fig"}C--E) but not of *Pde2a* ([Fig. 5](#f0025){ref-type="fig"}G), which is expressed in *Gucy2d*+ cells ([@bb0020] [@bb0055]). Interestingly, another soluble guanylate cyclase, *Gucy1b3*, is widely expressed in the MOE including in type B cells ([Fig. 5](#f0025){ref-type="fig"}F).

Thus, the gene expression profile of type B cells differs from canonical OSNs by the absence of expression of *Adcy3* and *Cnga4*.

2.6. The Gucy1b2-IRES-tauGFP knockin mouse strain {#s0050}
-------------------------------------------------

Next we generated an IRES-tauGFP knockin mutation at the *Gucy1b2* locus in the mouse germ line by gene targeting in embryonic stem (ES) cells. The *Gucy1b2* gene is located on chromosome 14. The RefSeq consists of 17 coding exons with two possible ATG translation initiation sites, encoding a putative polypeptide of 824 amino acids ([Fig. 6](#f0030){ref-type="fig"}A). The amino acid sequence of this and other soluble guanylate cyclases features heme NO binding domains HNOB and HNOBA, and a cyclase homology domain CHD. We inserted an IRES-tauGFP cassette immediately after the STOP codon of *Gucy1b2* ([Fig. 6](#f0030){ref-type="fig"}B), according to the same design as the Trpc2-IRES-taumCherry mutation. This mouse strain is publicly available from The Jackson Laboratory.

In coronal MOE sections of a homozygous Gucy1b2-IRES-tauGFP mouse, the intrinsic fluorescence of GFP shows concordance with Gucy1b2 immunoreactivity ([Fig. 6](#f0030){ref-type="fig"}C). To reveal the morphology of the GFP + cells more clearly, we performed IHC with antibodies against GFP ([Fig. 6](#f0030){ref-type="fig"}D). A variety of cellular morphologies can be discerned among GFP + cells. In some cells fine apical features resembling either short cilia or microvilli can be discerned, and a further characterization of these structures awaits super-resolution or electron microscopy. The Gucy1b2-IRES-tauGFP strain will be useful for molecular, cellular, physiological, and anatomical studies of type B cells.

2.7. Axonal coalescence of type B cell axons into glomeruli {#s0055}
-----------------------------------------------------------

The expression level of the *Gucy1b2* locus is sufficiently high for tauGFP translated from the *IRES* sequence to decorate axonal processes of type B cells all the way to the olfactory bulb. In whole mounts of the main olfactory bulb (n = 14) of homozygous Gucy1b2-IRES-tauGFP mice at three weeks, 3.14 ± 0.21 major green-fluorescent glomeruli are visible on the ventral-posterior aspect ([Fig. 7](#f0035){ref-type="fig"}A). At postnatal day 7, the Gucy1b2 glomeruli appear to be fully mature. In a mouse double homozygous for Gucy1b2-IRES-tauGFP and Trpc2-IRES-taumCherry, the fluorescent signals overlap ([Fig. 7](#f0035){ref-type="fig"}B), corroborating the concordance of Gucy1b2 and Trpc2 expression in type B cells seen at the level of the MOE. In coronal sections of the main olfactory bulb of a homozygous Gucy1b2-IRES-tauGFP mouse, GFP intrinsic fluorescence overlaps with Omp and Cnga2 immunoreactive signals, and Adcy3 immunoreactivity is absent in the GFP + glomeruli ([Fig. 7](#f0035){ref-type="fig"}C). Thus, despite the apparent absence of expression of an OR or VR gene, axons of Gucy1b2 + MOE neurons coalesce into glomeruli that strongly resemble canonical glomeruli, which form in an OR-instructed fashion ([@bb0090; @bb0085]).

3. Discussion {#s0015}
=============

3.1. Gucy1b2 as a marker for type B cells in the MOE {#s0060}
----------------------------------------------------

Having established that Trpc2 expression is actually not restricted to VSNs in the mouse ([@bb0110]), we have here characterized type B cells molecularly and anatomically. This Trpc2 + cell type is confined to the lateral region of the mouse MOE, a region that is similar to that of the most highly expressed OR gene, *MOR28*/*Olfr1507* ([@bb0110]). Our previous ISH and IHC studies ([@bb0110]) had not revealed expression of a known chemosensory G-protein coupled receptor gene or component of a signaling pathway other than *Cnga2*, which is required for odorant-evoked signal transduction in canonical OSNs. The availability of the Trpc2-IRES-taumCherry knockin strain enabled us here to examine live, unfixed cells. Extensive single-cell analyses with degenerate RT-PCR did not reveal expression of the known chemosensory G-protein coupled receptor gene repertoires (*OR*, *Vmn1r*, *Vmn2r*, *Taar*, *Fpr*) in putative type B cells. But given the size and complexity of these repertoires, some of these genes may not be detectable by the degenerate RT-PCR primers. A definitive assessment of chemosensory receptor gene expression in type B cells awaits deep RNAseq, ideally of many single cells to exclude that a subset of type B cells may express some of these genes. Our interest in *Gucy1b2* was kindled by the unbiased, non-targeted, exploratory approach of LongSAGE, which is conceptually a precursor to RNAseq. ISH and IHC with a custom antibody confirm Gucy1b2 as a marker for type B cells within the MOE. The Gucy1b2-IRES-tauGFP knockin strain has been informative with regard to describing axonal coalescence into glomeruli in the bulb. The initial indication that the few ventral glomeruli in the main olfactory bulb of Trpc2-IRES-taulacZ mice correspond to type B cells ([@bb0110]) has now been proven in Gucy1b2-IRES-tauGFP mice. Unambiguous tracing of the axonal projections of type A cells to the bulb requires a marker for type A cells that is not expressed in type B cells, canonical OSNs, and VSNs.

3.2. cGMP-mediated signaling {#s0065}
----------------------------

*Cnga2* expression in type B cells in the absence of *Adcy3* expression raises the question as to which cyclic nucleotide (cAMP or cGMP) is available in these cells to activate this cyclic-nucleotide gated cation channel and what enzyme produces it. The disruption of the glomerular pattern of type B cells in Cnga2 knockout mice indicates that Cnga2 is functionally relevant for these cells ([@bb0110]). Gucy1b2 is a plausible candidate for the generation of cGMP, possibly as a heterodimer with type-a soluble guanylate cyclases. We find Gucy1b3 to be expressed in type B cells as well as, interestingly, in canonical OSNs. Further progress in the issue of signaling requires the identification of chemosensory stimuli for type B cells that do not act on canonical OSNs and on VSNs. It is tempting to speculate that gases such as nitrogen oxide and/or oxygen ([@bb0015; @bb0095; @bb0155; @bb0130]) stimulate type B cells via Gucy1b2. If that is the case, it remains to be determined if this pathway is the sole or the main chemosensory signaling pathway in these cells. It will be interesting and also challenging to dissect the functional interplay between three distinct signaling pathways in type B cells, involving Cnga2, Trpc2, and Gucy1b2. One or more of these signaling pathways could have a modulating or auxiliary role in chemosensory signal transduction, or may be involved in cellular differentiation or axon guidance rather than be essential for transduction. It is prudent to keep an open mind when designing and interpreting experiments to understand the unprecedented coexistence of these three pathways in the same cells. If Trpc2 affects type B cell function one way or the other, the traditional interpretation of the behavioral phenotypes of Trpc2 knockout mice ([@bb0060; @bb0145; @bb0050]) will become problematic.

Thus, for now, Gucy1b2 is merely a marker for type B cells. Functional characterization of Gucy1b2 requires appropriate and specific chemosensory stimuli and Gucy1b2 knockout mice.

4. Conclusion {#s0020}
=============

The unexpected discovery that the mouse MOE abounds with Trpc2 + cells ([@bb0110]) has raised a series of interesting questions. We have described two types of Trpc2 + MOE cells: type [A]{.ul} ([A]{.ul}dcy3 +) and type [B]{.ul} (Gucy1[b]{.ul}2 +). The Gucy1b-IRES-tauGFP mice will be useful for physiological studies of single cells, and for molecular, cellular, and anatomical studies of this newly discovered chemosensory subsystem. The soluble guanylate cyclase Gucy1b2 may be more than a marker for type B cells, and could be relevant for their chemosensory function. In any case, type B cells are not VSNs that are misplaced in the MOE, and their gene expression profile suggests that they are physiologically distinct from VSNs, sharing only *Trpc2* expression. Our results serve as further caution against the traditional interpretation of the behavioral phenotypes of Trpc2 knockout mice, as if only VSNs would be impaired in these mice, and no other neurons or no other cells in the mouse\'s body. Specifically, there is no reason to expect that Trpc2 + type B cells respond to pheromones.

5. Experimental methods {#s0070}
=======================

5.1. Generation of mouse strains with gene-targeted knockin mutations {#s0075}
---------------------------------------------------------------------

To generate the targeting vector for the Trpc2-IRES-taumCherry mutation, a 4.8 kb *HindIII--PvuII* fragment containing exons 9--13 of *Trpc2* was used for the left homology arm, and a 4.8 kb *PvuII--HindIII* fragment containing a part of exon 13 for the right homology arm. A *PacI--AscI* site was generated at the *PvuII* site located 32 bp after the STOP codon of *Trpc2*. The cassette *IRES-taumCherry-loxP-ACNF* was inserted in the newly generated *AscI* site. The vector was linearized and electroporated into E14 ES cells. Targeted ES cell clones were injected into C57BL/6 blastocysts, and chimeras were bred with wild-type C57BL/6 mice. A strain was established from ES clone A75. To generate the targeting vector for the Gucy1b2-IRES-tauGFP mutation, a 4.5 kb *BamHI* fragment containing a part of exon 17 and intron between exons 16 and 17 and a 6.7 kb *BamHI--EcoRV* fragment containing a part of exon 17 and 3′ of *Gucy1b2* gene were isolated from bacterial artificial chromosome clone bMQ-312D1 (Source Bioscience). An *AscI* site was generated immediately downstream of the STOP codon of *Gucy1b2*. The cassette *IRES-tauGFP-loxP-ACNF* was inserted in the newly generated *AscI* site. The vector was linearized and electroporated into E14 cells. Targeted ES clones were injected into C57BL/6 blastocysts, and chimeras were bred with wild-type C57BL/6 mice. A strain was established from ES clone C20. Mice were maintained in specified pathogen-free conditions in individually ventilated cages of the Tecniplast green line. Mouse experiments were carried out in accordance with NIH guidelines and the German Animal Welfare Act, European Communities Council Directive 2010/63/EU, and the institutional ethical and animal welfare guidelines of the Max Planck Institute of Biophysics and the Max Planck Research Unit for Neurogenetics. Approval came from the IACUC of The Rockefeller University and the *Veterinäramt* of the City of Frankfurt. The following two strains are publicly available from The Jackson Laboratory in a mixed 129 × C57BL/6 background: Trpc2-IRES-taumCherry as official strain name B6;129P2-Trpc2 \< tm2Mom \>/MomJ and JR\#6733, and Gucy1b2-IRES-tauGFP as official strain name B6;129P2-Gucy1b2 \< tm3Mom \>/MomJ and JR\#21063.

5.2. Single-cell RT-PCR {#s0080}
-----------------------

We dissected out WOM ([@bb0045]) from the lateral region of the MOE and VNE of Trpc2-IRES-taumCherry homozygous mice at 8 weeks and heterozygous OMP-tauYFP mice at 3 or 8 weeks. Tissue samples were dissociated with dispase (Invitrogen), collagenase (Invitrogen) and DNase I (Roche). We picked mCherry + cells or YFP + cells picked under an inverted fluorescence microscope (TE200-1, Nikon) using micromanipulators (N88NEN2, Nikon Narashige) ([@bb0010]). The isolated cells were washed individually at least three times in separate drops of buffer under mineral oil. The cells were transferred to 0.4 μl of nuclease-free water in each PCR tubes. The samples were immediately snap frozen. Reverse transcription and amplification of cDNA were conducted as described previously ([@bb0120]) with modifications.

For single cell RT-PCR, reverse transcription (RT) was performed with anchor-T primer (*TATAGAATTCGCGGCCGCTCGCGA*\[*T*\]24) and Superscript III (Invitrogen) for 90 min at 37 °C and 15 min at 50 °C. Reactions were stopped by heating at 70 °C for 10 min. Tailing reaction was followed with TdT (Roche), dATP (Roche) and RnaseH (Roche) for 20 min at 37 °C, then for 10 min at 65 °C. To validate *taumCherry* expression in the single cells, RT-tailed products were first amplified with mCherry-F1: *GGATAACATGGCCATCATCAAGG* and Trpc2 3′UTR-R: *CATCTGACTTCCACAGCAGA*. Then a second round of PCR was performed with mCherry-F2: *CTGTTCCACGATGGTGTAGTCC*, and mCherry-R1: *CGTAATGCAGAAGAAGACCATGG*. For analysis of expression of other genes, RT-tailed products were first amplified by PCR reaction with EX-Taq HS DNA polymerase (Takara) and anchor-T primer by incubating at 95 °C for 2 min, 37 °C for 5 min, 72 °C for 20 min, then 30 cycles of 95 °C for 30 s, 67 °C for 1 min, 72 °C for 6 min plus 6 s extension for each cycle, then 72 °C for 10 min. The second round of PCR was with the following primers: for *Omp*, Omp-F: *GCACAGTTAGCAGGTTCAGCT*, Omp-R: *GGTTTGCAGTCCTGGCAGC*, for *Gapdh*, Gapdh-F: *TTAGCCCCCCTGGCCAAGG*, Gapdh-R: *CTTACTCCTTGGAGGCCATG*, for *Cnga2*, Cnga2-F: *GGAGATCCTGATGAAGGAAGG*, Cnga2-R: *AACAGCTGGCTCAGGGGTGT*, for *Adcy3*, Adcy3-F: *GCATGAACAAAGGAGGGGTTC*, Adcy3-R: *TCAGGGGTTGTCCACCACTT*, for *Gnai2*, Gnai2-F: *GAGCATGAAGCTGTTTGACAGC*, Gnai2-R: *CTCCTTGGTGTCTTTGCGC*, for *Gnao1*, Gnao-F: *CTCCACGAGGACGAAACCAC*, Gnao-R: *GCCCCGGAGATTGTTGGCA*, for *Gnal* ([@bb0115]). For *OR* genes, we used generate RT-PCR primer sets D1--D2 and D4--D6 ([@bb0100]), and P26--P27 ([@bb0080]). For *Taar* genes, we used Taar-F: *TIGAGRGMTGCTGGTAYTTYGG* and Taar-R: *RGTYTTKGCWGCYTTYCTITC*. For *Vmn1r* genes, we used the 11 primer sets (V1ra-V1rk) as previously described ([@bb0115]). For family-C *Vmn2r* genes, we used for set A, Family-C-F1: *AAGCCATGCAACTGGTCCTG* and Family-C-R1: *GCATTCAAAGATGATCTTTACA*, and for set B, Family-C-F1 and Family-C-R2: *GACAAAAGAGATCCAGACAATG*. For *Fpr* genes, we used for set A, Fpr-F1: *TTCTTTGTCTGTTGGTTCCC* and Fpr-R1: *ACATAGAGTATTGGGTTGAG*, and for set B, Fpr-F2: *TCTTGACTACAGTGAGAGATG* and Fpr-R2: *GAGGACACGTAAAGGACG*. Primers for *Fpr-rs1* were: Fpr-rs1-F, *ATCCTGGGGCAACTCTGTTGAG* and Fpr-rs1-R: *CACAGCCCCCTCCTCATATT*.

5.3. LongSAGE {#s0085}
-------------

All steps until the first amplification of cDNA were done as described for single-cell RT-PCR except for the RT reactions: these were done with biotin anchor-T primer (biotin-*TATAGAATTCGCGGCCGCTCGCGA\[T\]*24) and Superscript III (Invitrogen) for 10 min at 37 °C and 10 min at 50 °C then for 10 min at 65 °C. A biotin-anchor-T primer was used also first amplification step. Amplified PCR products were screened for expression of *Gapdh*, *Omp*, *mCherry*, *Adcy3*, *Cnga2* and *Gnao* with gene-specific primers. Samples m85 and m93 from cells (*Gapdh*, *Omp*, *mCherry*, *Cnga2* and *Gnao* positive, and *Adcy3* negative) and v28 (*Gapdh*, *Omp*, *mCherry*, and *Gnao* positive) from the VNO were analyzed using LongSAGE ([@bb0125]) according to the protocol published at <http://www.sagenet.org/protocol/index.htm>. Briefly, amplified single-cell PCR products were digested with anchoring enzyme *NlaIII* (New England BioLabs). Cleaved samples were divided into two fractions and were bound to streptavidin magnetic beads (Dynal), and linkers were ligated. The ligated DNA was digested with tagging enzyme *MmeI* (NEB). The cleaved tags were ligated to form ditags and amplified by PCR. The PCR product was cleaved with anchoring enzyme *NlaIII* and the ditags were ligated to form concatemers. The concatemers were cloned into pZero-1 vector (Invitrogen). Clones were picked and sequenced. Tag sequences were analyzed using SAGE2002 software (Johns Hopkins University) and NCBI Blast searches.

5.4. In situ hybridization {#s0090}
--------------------------

ISH was performed as described ([@bb0025]). The following riboprobes have been described previously: *Omp* ([@bb0025]), *Trpc2*, *Adcy3*, and *Cnga2* ([@bb0110]). We used a mix of two riboprobes for *Gucy1b2*: riboprobe 1, nt 951--2040, and riboprobe 2, nt 1747--2630 from [NM_172810.3](ncbi-n:NM_172810.3){#ir0050}. We designed riboprobes for *Cnga4*, nt 125--1263 from [NM_001033317.3](ncbi-n:NM_001033317.3){#ir0055}; for *Pde1c*, nt 1253--2398 from [NM_001025568](ncbi-n:NM_001025568){#ir0060}; for *Pde2a*, nt 2361--3358 from [NM_001008548](ncbi-n:NM_001008548){#ir0065}; for *Pde4a*, nt 2077--2838 from [NM_183408](ncbi-n:NM_183408){#ir0070}; for *Pde6d*, nt 153--908 from [NM_008801.2](ncbi-n:NM_008801.2){#ir0075}; and for *Gucy1b3*, nt 1901--2835 from [NM_017469](ncbi-n:NM_017469){#ir0080}. Images were collected with a Zeiss LSM 710 confocal microscope.

5.5. Generation of antibodies against mouse Gucy1b2 {#s0095}
---------------------------------------------------

As antigen for raising antibodies against mouse Gucy1b2 protein, we used the 22 amino-acid peptide RPSALADGKEASTPRNQVKKPR (654--675 in the Gucy1b2 sequence), which is C-terminal to the predicted catalytic domain CHD. Rabbit antiserum (ImmunoGlobe, Himmelstadt, Germany) was raised against KLH-conjugated polypeptide (Schafer-N Copenhagen, Denmark). Antibodies were affinity-purified with using affinity columns conjugated with the synthetic peptide.

5.6. Immunohistochemistry {#s0100}
-------------------------

Mice were anesthetized by injection of ketamine HCl and xylazine (210 mg/kg and 10 mg/kg body weight, respectively) and perfused with ice-cold PBS, followed by 4% PFA in PBS. The mouse heads were dissected, post-fixed in 4% PFA, and decalcified in 0.45 M EDTA in 1 × PBS overnight at 4 °C. Samples were cryoprotected in 15% and 30% sucrose in 1 × PBS at 4 °C, frozen in O.C.T. compound (Tissue-Tek), and sectioned at 12 μm with a Leica CM3500 cryostat. Sections were washed with 1 × PBS. Washed sections were blocked with 10% normal goat serum or normal donkey serum, 0.1% Triton X-100 in 1 × PBS for 1 h at room temperature. After the blocking step, sections were incubated in 3% BSA, 0.1% Triton X-100 in 1 × PBS for overnight at 4 °C with the following primary antibodies: rabbit anti-Gucy1b2 (1:500), rabbit anti-Trpc2 (1:500, [@bb0075]), goat anti-Omp (1:1000, Wako Chemicals), rabbit anti-Adcy3 (1:1000, Santa Cruz Biotechnology), goat anti-Cnga2 (1:100, Santa Cruz Biotechnology), and chicken anti-GFP (1:3000, Aves Labs). After incubation with primary antibodies, sections were incubated at 1.5 h at room temperature with secondary antibodies: goat anti-rabbit IgG-Alexa647 (Molecular Probes) for rabbit anti-Trpc2 in [Fig. 1](#f0005){ref-type="fig"}B, goat anti-rabbit IgG-Alexa488 (Molecular Probes) for rabbit anti-Gucy1b2 in [Figs. 4](#f0020){ref-type="fig"}B, goat anti-rabbit IgG-Alexa546 (Molecular Probes) for rabbit anti-Gucy1b2 in [Fig. 6](#f0030){ref-type="fig"}C, goat anti-chicken IgG Alexa488 (Molecular Probes) in [Fig. 6](#f0030){ref-type="fig"}D, donkey anti-rabbit IgG Alexa555 (Molecular Probes) for rabbit anti-Adcy3 in [Fig. 7](#f0035){ref-type="fig"}C, donkey anti-goat IgG Cy5 (Jackson ImmunoResearch) for goat anti-Omp, and goat anti-Cnga2 in [Fig. 7](#f0035){ref-type="fig"}C. For sections of the olfactory bulb, nuclear staining was with DAPI (1:10,000, Molecular Probes) after the washing steps. Sections were analyzed with a Zeiss LSM 710 confocal microscope.
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![Trpc2-IRES-taumCherry gene-targeted strain. (A) Generation of a Trpc2-IRES-taumCherry knockin mutation in the mouse germline. The *IRES-taumCherry-ANCF* cassette was inserted after the STOP codon of *Trpc2* by homologous recombination with a targeting vector in ES cells. The *ACNF* cassette is a self-excising *neo* gene that is removed during the transmission of the targeted allele through the male germ line, leaving a single *loxP* site (red triangle) behind in the locus. The axonal marker taumCherry is a fusion protein between bovine tau and mCherry and is intrinsically red fluorescent. (B) Intrinsic red fluorescence of taumCherry (mCherry\*) of sections of the VNO and MOE of homozygous Trpc2-IRES-taumCherry mice at eight weeks, combined with IHC (green) for Trpc2. The fusion of mCherry to tau promotes subcellular localization at dendritic tips and axons compared to cell bodies. (C) Whole mount view of the olfactory system of a homozygous Trpc2-IRES-taumCherry mouse at four weeks, intrinsic red fluorescence (mCherry\*). (Left) Axons project from the VNO across the nasal septum in the form of several vomeronasal fascicles. (Middle) Most axons terminate in the accessory olfactory bulb (AOB). (Right) Some axons coalesce into a few glomeruli ventrally in the main olfactory bulb (MOB). The red arrowhead indicates the vomeronasal nerve. Scale bar: 50 μm in B top left; 20 μm in B other panels; 500 μm in C left; 200 μm in C middle and right.](gr1){#f0005}

![Single-cell RT-PCR of red-fluorescent cells from Trpc2-IRES-taumCherry mice. (A) Ethidium-bromide stained agarose gels of RT-PCR products generated from a single red-fluorescent cell (m37) isolated from lateral WOM of a homozygous Trpc2-IRES-taumCherry mouse at eight weeks, in comparison with RT-PCR products of WOM of a WT C57BL/6 mouse at eight weeks (OE), PCR products of genomic DNA (mut) from a homozygous Trpc2-IRES-taumCherry mouse as positive control for mCherry, and buffer (buf) as negative control. (B) Degenerate RT-PCR with primers for OR genes does not reveal OR gene expression in 15 single cells isolated from lateral WOM of a homozygous Trpc2-IRES-taumCherry mouse at eight weeks. We cloned some of the faint bands and found that they did not represent OR genes. A strong RT-PCR product is obtained with o1 and o2, two single cells isolated from WOM of a heterozygous OMP-YFP gene-targeted mouse at three weeks. buf16 is buffer, as negative control. (C) Degenerate RT-PCR for the *V1rg* family of *Vmn1r* genes reveals a product in one of six single red-fluorescent cells (v10) isolated from the VNO a homozygous Trpc2-IRES-taumCherry mouse at eight weeks. By contrast, no RT-PCR products are obtained from nine single red-fluorescent cells (such as m2) picked from lateral WOM. Lanes labeled with buf are with buffer, as negative control. (D) RT-PCR for the family-C *Vmn2r* genes reveals a product in a single red-fluorescent cell (v28) isolated from the VNO a homozygous Trpc2-IRES-taumCherry mouse at eight weeks, but not from six single red-fluorescent cells (such as m62) isolated from lateral WOM of a homozygous Trpc2-IRES-taumCherry mouse at eight weeks. A and B are two distinct primer sets. Lanes labeled with buf are with buffer, as negative control. VNO represents cDNA from whole vomeronasal organ, and Gen represents genomic DNA of a WT C57BL/6 mouse.](gr2){#f0010}

![Long Serial Analysis of Gene Expression (LongSAGE) of single red-fluorescent cells from Trpc2-IRES-taumCherry mice. (A) Example of nucleotide sequence of a LongSAGE clone recovered from m93, a red-fluorescent cell isolated from WOM in the lateral region of the MOE of a homozygous Trpc2-IRES-taumCherry mouse at eight weeks. The sequence of the tag representing the gene *Omp* is highlighted in yellow, and the anchoring *NlaIII* recognition sites *CATG* are highlighted in red. (B) Example of nucleotide sequence of another LongSAGE clone recovered from m93. The tag representing the gene *Gucy1b2* highlighted. The sequence of the tag representing the gene *Gucy1b2* is highlighted in yellow, and the anchoring *NlaIII* recognition sites *CATG* are highlighted in red. (C) Summary of tags analyzed in cells m85 and m93 (type B cells) and cell v28 (VNO cell). For *Gucy1b2*, we identified 8/5195 tags (0.15%) in sample m85, and 9/5653 tags (0.16%) in sample m93, compared to 0/5998 tags in the v28 sample. Sample v28 contains tags for family-ABD *Vmn2r* and family-C *Vmn2r* genes: 44 tags (0.73%) for *Vmn2r42* or *Vmn2r37* (three independent tags were found, however, unfortunately the 17 bp tags are identical in these *Vmn2r* genes), and 5 tags (0.08%) for *Vmn2r7* from family C.](gr3){#f0015}

![*Gucy1b2* RNA and Gucy1b2 protein expression in type B but not type A Trpc2 + MOE cells. (A) ISH with riboprobes for *Trpc2*, *Gucy1b2*, and *Adcy3* in coronal sections of the MOE of a wild-type C57BL/6 mouse at eight weeks. Type A cells, which are *Adcy3*+ and have their cell bodies typically just under the sustentacular layer, are *Gucy1b2*−. By contrast, type B cells, which are *Adcy3*− and have their cell bodies at all positions along the basal-to-apical dimension of the MOE, are *Gucy1b2*+. This section through the lateral region of the MOE, where type B cells are concentrated, also contains one *Gucy1b2- Trpc2+ Adcy3+* cell (arrowhead); this could be a type A cell, for which there is no unique marker. (B) IHC with antibodies against Gucy1b2 and intrinsic red fluorescence of taumCherry (mCherry\*), in coronal sections of the MOE of a wild-type C57BL/6 mouse at two weeks. Type A cells are not immunoreactive for the Gucy1b2 antibody. By contrast, type B cells are Gucy1b2 +. This section through the lateral region of the MOE contains two faintly mCherry\* cells that are Gucy1b2 − (arrowheads) and could be type A cells. Scale bar, 10 μm.](gr4){#f0020}

![Expression of other signaling molecules in *Gucy1b2*+ MOE cells. ISH in coronal sections of the MOE of a wild-type C57BL/6 mouse at 8 weeks. *Gucy1b2*+ cells are also *Cnga2*+ (A) but *Cnga4*− (B). These cells express the phosphodiesterases *Pde1c* (C) and *Pde4a* (D), as do canonical OSNs. The cGMP-specific phosphodiesterase *Pde6d* (E) and *Gucy1b3* (F) are expressed in *Gucy1b2*+ cells, as well as in all other *Omp*+ OSNs. *Gucy1b2*+ cells are *Pde2a*− (G). Scale bar, 10 μm.](gr5){#f0025}

![Gucy1b2-IRES-tauGFP gene-targeted strain: main olfactory epithelium. (A) The mouse *Gucy1b2* gene is located on chromosome 14 and consists of 17 coding exons. The various domains of the four known soluble guanylate cyclases are HNOB, HNOBA, and CHD. (B) The Gucy1b2-IRES-tauGFP knockin mutation was generated by gene targeting in ES cells. The *IRES-tauGFP-ANCF* cassette was inserted after the STOP codon of *Gucy1b2* by homologous recombination in ES cells. The *ACNF* cassette, a self-excising neo gene, was removed during transmission of the targeted allele through the male germ line, leaving a single *loxP* site (red triangle) behind in the locus. The *IRES* sequence allows for the cotranslation of intact Gucy1b2 (regardless of which ATG is used for initiation of translation) with the axonal green-fluorescent marker tauGFP. (C) IHC of a coronal section of the MOE of a homozygous Gucy1b2-IRES-tauGFP mouse at 4 weeks shows concordance of the intrinsic fluorescence of GFP (GFP\*) with the immunoreactive signal for Gucy1b2. (D) IHC of a coronal section of the MOE of a homozygous Gucy1b2-IRES-tauGFP mouse at three weeks with antibodies against GFP. The immunoreactive GFP + cells i through vii exhibit various morphologies and intra-epithelial locations. Nuclear staining is with DAPI. Scale bar, 50 μm in C; 50 μm in D left; 10 μm in Di--vii.](gr6){#f0030}

![Gucy1b2-IRES-tauGFP gene-targeted strain: main olfactory bulb. (A) (Left) Ventral view of a whole mount of a homozygous Gucy1b2-IRES-tauGFP mouse at three weeks, showing intrinsic fluorescence of GFP (GFP\*). (Middle) High magnification of a ventromedial glomerulus in the right bulb of the same mouse. (Right) At postnatal day 7, GFP + axons have already coalesced into glomeruli. (B) Whole mount view of a main olfactory bulb of mouse double homozygous for Gucy1b2-IRES-GFP and Trpc2-IRES-taumCherry at four weeks. Fluorescent axons coalesce into a few glomeruli. The signals with green (GFP\*) and red (mCherry\*) intrinsic fluorescence overlap precisely. (C) IHC of coronal sections of the glomerular layer in the main olfactory bulb of a homozygous Gucy1b2-IRES-tauGFP at eight weeks. Intrinsic GFP fluorescence (GFP\*) overlaps with immunoreactivity for Omp and Cnga2 but not for Adcy3, consistent with expression in type B cells. Scale bar, 500 μm in A left and right; 50 μm in A middle; 200 μm in B; 50 μm in C.](gr7){#f0035}
